Expression of LKB1 in different molecular subtype of breast carcinoma

Zhi-gang ZHUANG,Qi-zhi HE,Bei-qi JIANG,Zheng-dong LI,Wei JIN
DOI: https://doi.org/10.3969/j.issn.1672-4992.2010.12.24
2010-01-01
Journal of Modern Oncology
Abstract:Objective:To investigate the expression of LKB1 and its significance in different molecular subtype breast carcinomas.Methods:Tissue micro-array and immunohistochemical methods were used to determine the expression of LKB1 and other markers(ER,PR,HER-2,CK56 and P53) in 180 cases of breast invasive ductal carcinoma(IDC),18 cases of ductal carcinoma in suit(DCIS) and 20 cases of normal breast tissue.These cases were grouped based on clinicopathological characteristics and molecular subtypes of breast carcinoma,and the different expressions of LKB1 in individual groups were evaluated.Results:The expressions of LKB1 of IDC(66/180,36.67%) and DCIS(11/18,66.11%) were significantly different(P < 0.05) 2.The expressions of LKB1 were strongly associated with lymph node involvement(P < 0.01) It was significantly different among those groups of different molecular subtype(P < 0.05) Among them,the P value was 0.0218 between the luminal A and the HER-2 + groups.Conclusion:The expression of LKB1 in IDC is significantly lower than that in DCIS and is negatively related to lymphnode metastasis,there are also lower levels of expression in the HER-2 + and the triple negative groups.This suggests that LKB1 is inhibited in the process of progression and metastasis in breast cancer.
What problem does this paper attempt to address?